REQUEST A DEMO
Total
USD $0.00
Search more companies

Inpharm Co D.O.O. (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inpharm Co D.O.O. Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Inpharm Co D.O.O. is an enterprise in Serbia, with the main office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on May 17, 1990. Inpharm Co D.O.O. currently employs 156 (2024) people. The latest financial highlights indicate a net sales revenue increase of 7.44% in 2024. Its’ total assets recorded a growth of 46.21%. The net profit margin of Inpharm Co D.O.O. decreased by 1.73% in 2024.

Headquarters
Batajnicki Drum 17 Deo 5
Belgrade; Belgrade;

Contact Details: Purchase the Inpharm Co D.O.O. report to view the information.

Website: http://www.inpharm.rs

Basic Information
Total Employees:
Purchase the Inpharm Co D.O.O. report to view the information.
Registered Capital:
Purchase the Inpharm Co D.O.O. report to view the information.
Financial Auditors:
Purchase the Inpharm Co D.O.O. report to view the information.
Incorporation Date:
May 17, 1990
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Bioclinica
Company Performance
Financial values in the chart are available after Inpharm Co D.O.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
7.44%
Total Operating Revenue
7.69%
Operating Profit
-15.36%
EBITDA
-11.86%
Net Profit/Loss for the Period
-16.5%
Total Assets
46.21%
Total Equity
34.57%
Operating Profit Margin
-1.99%
Net Profit Margin
-1.73%
Return on Equity (ROE)
-16.49%
Debt / Equity
51.15%
Quick Ratio
-0.13%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?